Antithrombotic drugs in relation to prostaglandin metabolism.
D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000453:epidemiology; D004176:Dipyridamole / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D005343:Fibrinolytic Agents; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D004930:Inuit; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000378:metabolism*; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy
D005343:Fibrinolytic Agents; D011453:Prostaglandins; D004176:Dipyridamole; D006493:Heparin; D001241:Aspirin; D013442:Sulfinpyrazone